Cell Penetrating Peptides as Potential Therapeutic Agents

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".

Deadline for manuscript submissions: closed (31 October 2024) | Viewed by 1937

Special Issue Editors


E-Mail Website
Guest Editor
Chemistry Institute, Faculty of Natural of Exact Sciences, University of Antioquia, A.A. 1226, Medellin 050010, Antioquia, Colombia
Interests: membrane biophysics; bioactive peptides; advanced techniques in biophysics; biophysics and molecular biology; infrared spectroscopy
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Basic Sciences and Morphology, Faculty of Medicine, Catholic University of the Holy Conception, Concepción 3349001, Chile
Interests: structure determination of biological macromolecules; X-ray diffraction and electron microscopy; interaction of molecules of biological interest with cell membranes

Special Issue Information

Dear Colleagues,

Membranes are barriers that provide an outer boundary for cells (plasma membranes) as well as their inner compartments (organelles). Membranes control the flow of information between cells, either by recognizing signal molecules received or by sending chemical or electrical signals to other cells. Therefore, biological membranes are more than just inert barriers or covers; they play active roles in the life of the cells. Many molecules, directly or indirectly, influence cell membrane properties; among these molecules, bioactive peptides have become relevant since they have shown a wide range of activities, including antibacterial, anticancer, antivirus, antiparasitic, antifungal, and also biofilm activity. The advances in peptides have centered the attention on a family of short peptides named cell-penetrating peptides (CPPs). The most accepted mechanism of action of bioactive peptides is related to membrane destabilization and disruption. For this reason, understanding how peptides interact with biological membranes and exert their activity at the molecular level is of critical significance in the pharmacological and biological fields.

This Special Issue aims to gather contributions related to the potential therapeutic use of CPP membrane models and biophysical techniques to better understand the peptide–membrane interaction, study of the mechanism of action, and potential therapeutic applications of bioactive peptides. Submissions on the discovery of new peptides or novel activities of well-known peptides are also encouraged.

All submission types, including original research articles and comprehensive reviews, are welcome.

Dr. Marcela Manrique Moreno
Prof. Dr. Mario Suwalsky
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cell-penetrating peptides (CPPs)
  • membrane-active peptides
  • biophysical techniques
  • lipid–peptide interaction
  • peptide mechanism of action

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 7191 KiB  
Article
Comparative Study of the Potential Cell-Penetrating Peptide ∆M4 on Apoptosis Cell Signaling in A375 and A431 Cancer Cell Lines
by Estefanía Fandiño-Devia, Aleksandra Brankiewicz, Gloria A. Santa-González, Ibeth Guevara-Lora and Marcela Manrique-Moreno
Pharmaceutics 2024, 16(6), 775; https://doi.org/10.3390/pharmaceutics16060775 - 7 Jun 2024
Cited by 1 | Viewed by 1415
Abstract
In recent yearsjajajj, peptide-based therapeutics have attracted increasing interest as a potential approach to cancer treatment. Peptides are characterized by high specificity and low cytotoxicity, but they cannot be considered universal drugs for all types of cancer. Of the numerous anticancer-reported peptides, both [...] Read more.
In recent yearsjajajj, peptide-based therapeutics have attracted increasing interest as a potential approach to cancer treatment. Peptides are characterized by high specificity and low cytotoxicity, but they cannot be considered universal drugs for all types of cancer. Of the numerous anticancer-reported peptides, both natural and synthetic, only a few have reached clinical applications. However, in most cases, the mechanism behind the anticancer activity of the peptide is not fully understood. For this reason, in this work, we investigated the effect of the novel peptide ∆M4, which has documented anticancer activity, on two human skin cancer cell lines. A novel approach to studying the potential induction of apoptosis by anticancer peptides is the use of protein microarrays. The results of the apoptosis protein study demonstrated that both cell types, skin malignant melanoma (A375) and epidermoid carcinoma (A431), exhibited markers associated with apoptosis and cellular response to oxidative stress. Additionally, ∆M4 induced concentration- and time-dependent moderate ROS production, triggering a defensive response from the cells, which showed decreased activation of cytoplasmic superoxide dismutase. However, the studied cells exhibited a differential response in catalase activity, with A375 cells showing greater resistance to the peptide action, possibly mediated by the Nrf2 pathway. Nevertheless, both cell types showed moderate activity of caspases 3/7, suggesting that they may undergo partial apoptosis, although another pathway of programmed death cannot be excluded. Extended analysis of the mechanisms of action of anticancer peptides may help determine their effectiveness in overcoming chemoresistance in cancerous cells. Full article
(This article belongs to the Special Issue Cell Penetrating Peptides as Potential Therapeutic Agents)
Show Figures

Graphical abstract

Back to TopTop